Literature DB >> 9024663

A new class of membrane-bound chemokine with a CX3C motif.

J F Bazan1, K B Bacon, G Hardiman, W Wang, K Soo, D Rossi, D R Greaves, A Zlotnik, T J Schall.   

Abstract

Chemokines direct the trafficking of white blood cells in immune surveillance, playing a key role in inflammatory and infectious diseases such as AIDS. All chemokines studied so far are secreted proteins of relative molecular mass approximately 7K-15K and fall into three families that are defined by a cysteine signature motif: CXC, CC and C (refs 3, 6, 7), where C is a cysteine and X any amino-acid residue. We report here the identification and characterization of a fourth human chemokine type, derived from non-haemopoietic cells and bearing a new CX3C fingerprint. Unlike other chemokine types, the polypeptide chain of the human CX3C chemokine is predicted to be part of a 373-amino-acid protein that carries the chemokine domain on top of an extended mucin-like stalk. This molecule can exist in two forms: either membrane-anchored or as a shed 95K glycoprotein. The soluble CX3C chemokine has potent chemoattractant activity for T cells and monocytes, and the cell-surface-bound protein, which is induced on activated primary endothelial cells, promotes strong adhesion of those leukocytes. The structure, biochemical features, tissue distribution and chromosomal localization of CX3C chemokine all indicate that it represents a unique class of chemokine that may constitute part of the molecular control of leukocyte traffic at the endothelium.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9024663     DOI: 10.1038/385640a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  508 in total

Review 1.  Role of chemokines in inflammation and immunoregulation.

Authors:  L Feng
Journal:  Immunol Res       Date:  2000       Impact factor: 2.829

Review 2.  The role of angiogenesis in rheumatoid arthritis: recent developments.

Authors:  A E Koch
Journal:  Ann Rheum Dis       Date:  2000-11       Impact factor: 19.103

Review 3.  Chemokines and central nervous system disorders.

Authors:  W J Karpus
Journal:  J Neurovirol       Date:  2001-12       Impact factor: 2.643

4.  Fractalkine (CX3CL1) as an amplification circuit of polarized Th1 responses.

Authors:  P Fraticelli; M Sironi; G Bianchi; D D'Ambrosio; C Albanesi; A Stoppacciaro; M Chieppa; P Allavena; L Ruco; G Girolomoni; F Sinigaglia; A Vecchi; A Mantovani
Journal:  J Clin Invest       Date:  2001-05       Impact factor: 14.808

Review 5.  Regulation of experimental autoimmune encephalomyelitis by chemokines and chemokine receptors.

Authors:  Adam Elhofy; Kevin J Kennedy; Brian T Fife; William J Karpus
Journal:  Immunol Res       Date:  2002       Impact factor: 2.829

6.  Spinal CX3CL1/CX3CR1 May Not Directly Participate in the Development of Morphine Tolerance in Rats.

Authors:  Yawen Peng; Genhua Guo; Bin Shu; Daiqiang Liu; Peng Su; Xuming Zhang; Feng Gao
Journal:  Neurochem Res       Date:  2017-08-03       Impact factor: 3.996

7.  T cell clonal expansions detected in patients with primary biliary cirrhosis express CX3CR1.

Authors:  Weici Zhang; Yoko Ono; Yoshinori Miyamura; Christopher L Bowlus; M Eric Gershwin; Emanual Maverakis
Journal:  J Autoimmun       Date:  2011-06-01       Impact factor: 7.094

8.  Regulation of CX3CL1 Expression in Human First-Trimester Decidual Cells: Implications for Preeclampsia.

Authors:  S Joseph Huang; Chie-Pein Chen; Lynn Buchwalder; Ya-Chun Yu; Longzhu Piao; Chun-Yen Huang; Frederick Schatz; Charles J Lockwood
Journal:  Reprod Sci       Date:  2019-01-03       Impact factor: 3.060

9.  Genetic disruption of fractalkine signaling leads to enhanced loss of cochlear afferents following ototoxic or acoustic injury.

Authors:  Tejbeer Kaur; Kevin K Ohlemiller; Mark E Warchol
Journal:  J Comp Neurol       Date:  2017-12-17       Impact factor: 3.215

10.  Cloning and functional characterization of the human fractalkine receptor promoter regions.

Authors:  Alexandre Garin; Philippe Pellet; Philippe Deterre; Patrice Debré; Christophe Combadière
Journal:  Biochem J       Date:  2002-12-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.